Dr. Tamaroff’s research program focuses on the use of wearable technology and the intersection between glycemia, insulin sensitivity, and cardiac disease. She has evaluated the use of continuous glucose monitors and the relationship between dysglycemia and cardiomyopathy in individuals with Friedreich’s Ataxia. She is currently investigating similar questions in individuals with Duchenne Muscular Dystrophy (DMD). Additionally, in individuals with DMD or pseudohypoparathyroidism, she is assessing the utility of remote monitoring during research studies to assess glycemia, activity, heart rate, and sleep.

Dr. Tamaroff is currently completing a Master of Science in Clinical Investigation (MSCI) to gain additional expertise in clinical research. In 2023 she was named a Vanderbilt Scholar in Diabetes through the Vanderbilt Diabetes Research and Training Center and received the Turner Hazinski Award through the Department of Pediatrics. She has received external grant funding from the National Institutes of Health, the Friedreich’s Ataxia Research Alliance, and the American Heart Association.